Detalles de la búsqueda
1.
Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled InRange trial.
Diabetes Obes Metab;
25(2): 545-555, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36263928
2.
Real-world outcomes of addition of insulin glargine 300 U/mL (Gla-300) to glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in people with type 2 diabetes: The DELIVER-G study.
Diabetes Obes Metab;
24(8): 1617-1622, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35491520
3.
How many people with type 2 diabetes fulfil the eligibility criteria for randomized, controlled trials of insulin glargine 300 U/mL in a real-world setting?
Diabetes Obes Metab;
23(3): 838-843, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33236461
4.
Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial.
Diabetes Obes Metab;
23(7): 1588-1593, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33687748
5.
Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial.
Diabetes Obes Metab;
22(8): 1369-1377, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32243043
6.
Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT study.
Diabetes Obes Metab;
22(3): 346-354, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31646724
7.
The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world setting.
Diabetes Obes Metab;
21(6): 1429-1436, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30768845
8.
Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D real-world study.
Diabetes Obes Metab;
21(9): 2123-2132, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31144445
9.
Switching to insulin glargine 300 units/mL in real-world older patients with type 2 diabetes (DELIVER 3).
Diabetes Obes Metab;
21(11): 2384-2393, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31264346
10.
Real-world evidence concerning clinical and economic outcomes of switching to insulin glargine 300 units/mL vs other basal insulins in patients with type 2 diabetes using basal insulin.
Diabetes Obes Metab;
20(5): 1293-1297, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29272064
11.
Clinical outcomes in real-world patients with type 2 diabetes switching from first- to second-generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study.
Diabetes Obes Metab;
20(9): 2148-2158, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29938887
12.
Dual metabolic defects are required to produce hypertriglyceridemia in obese subjects.
Arterioscler Thromb Vasc Biol;
31(9): 2144-50, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21778423
13.
Expression of ceramide-metabolising enzymes in subcutaneous and intra-abdominal human adipose tissue.
Lipids Health Dis;
11: 115, 2012 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-22974251
14.
Clinical outcomes in high-hypoglycaemia-risk patients with type 2 diabetes switching to insulin glargine 300 U/mL versus a first-generation basal insulin analogue in the United States : Results from the DELIVER High Risk real-world study.
Endocrinol Diabetes Metab;
5(1): e00306, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34807513
15.
Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease.
Gastroenterology;
139(6): 1961-1971.e1, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20600015
16.
Long-TE 1H MRS suggests that liver fat is more saturated than subcutaneous and visceral fat.
NMR Biomed;
24(3): 238-45, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20821410
17.
A review of reusable insulin pens and features of TouStar-a new reusable pen with a dedicated cartridge.
Diabetol Metab Syndr;
13(1): 147, 2021 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34924015
18.
Allele-specific regulation of MTTP expression influences the risk of ischemic heart disease.
J Lipid Res;
51(1): 103-11, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19546343
19.
Nonalcoholic fatty liver disease: detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decoupling.
Radiology;
256(2): 466-73, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20656836
20.
Characterizing human adipose tissue lipids by long echo time 1H-MRS in vivo at 1.5 Tesla: validation by gas chromatography.
NMR Biomed;
23(5): 466-72, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20099371